Showing results (31-40 of 316) with videos related to
Sort By:
Pageof 32
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2014
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical useLaura Zanotti, Alberto Bottini, Camillo Rossi, et al.Cancers|November 11, 2022
The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic DatasetsAndrea Rocca, Luca Braga, Maria Concetta Volpe, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Positron emission tomography and neoadjuvant therapy of breast cancerAlexandre Cochet, Daniele Generali, Stephen B Fox, et al.Anti-Cancer Drugs|February 25, 2016
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipientAlberto Bonetta, Laura Bandera, Giandomenico Roviello, et al.International Journal of Molecular Sciences|March 20, 2020
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better TreatmentsSobhani Navid, Chunmei Fan, Pedro O Flores-Villanueva, et al.Oncotargets and Therapy|August 18, 2017
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancerGiandomenico Roviello, Silvia Paola Corona, Alberto Bonetta, et al.Current Opinion in Oncology|July 16, 2024
Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensificationFrancesca Poggio, Chiara Molinelli, Irene Giannubilo, et al.Clinical Medicine Insights. Oncology|October 28, 2025
Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical InsightsMartina Catalano, Alberto D'Angelo, Francesco De Logu, et al.Expert Opinion on Therapeutic Targets|May 17, 2014
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Francesca Bedussi, Alberto Bottini, Maurizio Memo, et al.Molecules (Basel, Switzerland)|October 23, 2021
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-AnalysisNavid Sobhani, Giandomenico Roviello, Alberto D'Angelo, et al.Pageof 32